These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33316298)

  • 1. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance.
    Wang H; Ellipilli S; Lee WJ; Li X; Vieweger M; Ho YS; Guo P
    J Control Release; 2021 Feb; 330():173-184. PubMed ID: 33316298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-displaying-exosomes using RNA nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression.
    Ellipilli S; Wang H; Binzel DW; Shu D; Guo P
    Nanomedicine; 2023 Jun; 50():102667. PubMed ID: 36948369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.
    Xue H; Yu Z; Liu Y; Yuan W; Yang T; You J; He X; Lee RJ; Li L; Xu C
    Int J Nanomedicine; 2017; 12():5271-5287. PubMed ID: 28769563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
    Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
    Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.
    Zhou Q; Ching AK; Leung WK; Szeto CY; Ho SM; Chan PK; Yuan YF; Lai PB; Yeo W; Wong N
    Int J Oncol; 2011 Mar; 38(3):721-31. PubMed ID: 21240457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
    Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
    Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy.
    Shen S; Sun CY; Du XJ; Li HJ; Liu Y; Xia JX; Zhu YH; Wang J
    Biomaterials; 2015 Nov; 70():71-83. PubMed ID: 26302232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine.
    Kishikawa T; Otsuka M; Tan PS; Ohno M; Sun X; Yoshikawa T; Shibata C; Takata A; Kojima K; Takehana K; Ohishi M; Ota S; Noyama T; Kondo Y; Sato M; Soga T; Hoshida Y; Koike K
    Oncotarget; 2015 Apr; 6(10):8339-52. PubMed ID: 25826076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.
    Patil YB; Swaminathan SK; Sadhukha T; Ma L; Panyam J
    Biomaterials; 2010 Jan; 31(2):358-65. PubMed ID: 19800114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor efficacy of PD-1-conjugated PTX- and ZSQ-loaded nanoliposomes against multidrug-resistant liver cancers.
    Gu M; Yin F; Qin Y; Tian Y; Xiu X; Shen H; Zhu J
    Drug Deliv Transl Res; 2022 Oct; 12(10):2550-2560. PubMed ID: 35031972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
    Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
    Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
    Gao DY; Lin TsT; Sung YC; Liu YC; Chiang WH; Chang CC; Liu JY; Chen Y
    Biomaterials; 2015 Oct; 67():194-203. PubMed ID: 26218745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma.
    Wu M; Zhong C; Zhang Q; Wang L; Wang L; Liu Y; Zhang X; Zhao X
    J Nanobiotechnology; 2021 Feb; 19(1):39. PubMed ID: 33549107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.